Literature DB >> 6338138

Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system.

T S Larson, K Hudson, J I Mertz, J C Romero, F G Knox.   

Abstract

The injection of contrast medium into the renal artery causes a biphasic change in renal blood flow, a transient vasodilation followed by a more prolonged vasoconstrictive phase. The role of sodium balance in the vasoconstrictive response to contrast medium was evaluated in sodium-deplete dogs (n = 5) and sodium-replete dogs (n = 5). Contrast medium, 2 ml of diatrizoate solution per 4 sec, was injected into the renal artery in anesthetized dogs. Renal blood flow was 117 +/- 25 ml/min and 173 +/- 12 in the sodium-deplete and sodium-replete dogs, respectively. After the injection of contrast medium and following the transient vasodilation phase, renal blood flow significantly decreased from baseline by 42.2% +/- 4.2 and 12.2% +/- 1.1 in sodium-deplete and sodium-replete dogs, respectively. The duration of the vasoconstriction phase was significantly prolonged in the sodium-deplete dogs, 343 +/- 27 sec vs. 147 +/- 48 in sodium-replete dogs. Blockade of the intrarenal renin-angiotensin system with the renal artery infusion of Sar1-Ala8-All (50 micrograms/kg/min) did not significantly alter the magnitude of vasoconstrictive response to contrast medium in sodium-deplete animals; however, the duration of the vasoconstrictive phase was decreased from 277 +/- 59 sec to 86 +/- 13. We conclude that (1) sodium depletion accentuates both the magnitude and duration of the vasoconstrictive phase of the renal blood flow response to injection of contrast medium and (2) blockade of the intrarenal renin-angiotensin system shortens the duration of this response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338138

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

1.  Intravenous urography with iopamidol in children with reflux and obstructive nephropathy: effects on glomerular and tubular functions and the renin-angiotensin-aldosterone system.

Authors:  M Bosio; F Bissoli; G Vignati; M G Fiori
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

Review 2.  An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure.

Authors:  M K Dishart; J A Kellum
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

3.  Radiocontrast-induced renal failure.

Authors:  R T Misson; R E Cutler
Journal:  West J Med       Date:  1985-05

4.  Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat.

Authors:  Y Agmon; H Peleg; Z Greenfeld; S Rosen; M Brezis
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Acute renal failure with selective medullary injury in the rat.

Authors:  S N Heyman; M Brezis; C A Reubinoff; Z Greenfeld; C Lechene; F H Epstein; S Rosen
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 6.  [What is reliable in prevention of contrast medium-induced nephropathy?].

Authors:  C B Friedrichsohn; W Riegel; H Köhler
Journal:  Med Klin (Munich)       Date:  1997-06-15

Review 7.  Hemodynamic and tubular changes induced by contrast media.

Authors:  Antonella Caiazza; Luigi Russo; Massimo Sabbatini; Domenico Russo
Journal:  Biomed Res Int       Date:  2014-02-11       Impact factor: 3.411

Review 8.  Pharmacological strategies to prevent contrast-induced acute kidney injury.

Authors:  Pattharawin Pattharanitima; Adis Tasanarong
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

9.  Sildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injury.

Authors:  D Adam Lauver; E Grant Carey; Ingrid L Bergin; Benedict R Lucchesi; Hitinder S Gurm
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

Review 10.  Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models.

Authors:  Norbert Kiss; Péter Hamar
Journal:  Biomed Res Int       Date:  2016-11-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.